Clarivate PLC $CLVT Shares Sold by Clarkston Capital Partners LLC

Clarkston Capital Partners LLC decreased its position in Clarivate PLC (NYSE:CLVT) by 34.1% during the 1st quarter, HoldingsChannel.com reports. The firm owned 42,846,530 shares of the company’s stock after selling 22,125,604 shares during the period. Clarivate makes up 8.3% of Clarkston Capital Partners LLC’s investment portfolio, making the stock its 2nd biggest holding. Clarkston Capital Partners LLC owned 0.07% of Clarivate worth $108,402,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Personal CFO Solutions LLC acquired a new stake in shares of Clarivate in the first quarter valued at approximately $30,000. Principal Financial Group Inc. acquired a new position in Clarivate during the first quarter worth $32,000. M&T Bank Corp bought a new position in Clarivate in the fourth quarter valued at $34,000. Parallel Advisors LLC increased its stake in Clarivate by 94.2% in the 1st quarter. Parallel Advisors LLC now owns 13,786 shares of the company’s stock valued at $35,000 after buying an additional 6,687 shares during the last quarter. Finally, Jump Financial LLC acquired a new stake in Clarivate in the 4th quarter valued at $41,000. 85.72% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Wall Street Zen upgraded shares of Clarivate from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Barclays boosted their price target on Clarivate from $2.40 to $2.50 and gave the stock an “underweight” rating in a research report on Tuesday, July 7th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Clarivate in a research note on Wednesday, June 24th. Four research analysts have rated the stock with a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Reduce” and a consensus price target of $2.98.

Clarivate Stock Performance

Shares of NYSE CLVT opened at $1.95 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 0.89. The company has a market capitalization of $1.24 billion, a P/E ratio of -9.26 and a beta of 1.38. Clarivate PLC has a 12 month low of $1.66 and a 12 month high of $4.77. The stock has a 50 day moving average of $2.31 and a 200-day moving average of $2.47.

Clarivate (NYSE:CLVT) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.04. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.The business had revenue of $585.50 million during the quarter, compared to the consensus estimate of $569.50 million. During the same quarter last year, the firm posted $0.14 EPS. The company’s quarterly revenue was down 1.4% on a year-over-year basis. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. As a group, equities research analysts predict that Clarivate PLC will post 0.65 EPS for the current year.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.